EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction

Joanna Klimek iD, Oskar Kruc iD, Joanna Ceklarz, Beata Kamińska iD, Bogdan Musielak iD, Robin van der Straat iD, Alexander Dӧmling iD, Tad A Holak iD, Damian Muszak iD, Justyna Kalinowska-Tłuścik iD, Łukasz Skalniak iD, Ewa Surmiak iD

Molecules · 04.06.2024 · 29 (11) · 2646

DOI: 10.3390/molecules29112646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 04.06.2024. Verfasst von Joanna Klimek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland. Hauptthemen laut MEDLINE: B7-H1 Antigen, Programmed Cell Death 1 Receptor, Molecular Docking Simulation, Protein Binding. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Foundation for Polish Science, European Union in the framework of the Smart Growth Operational Program, Measure 4.2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PD-1/PD-L1 complex is an immune checkpoint responsible for regulating the natural immune response, but also allows tumors to escape immune surveillance. Inhibition of the PD-1/PD-L1 axis positively contributes to the efficacy of cancer treatment. The only available therapeutics targeting PD-1/PD-L1 are monoclonal antibody-based drugs, which have several limitations. Therefore, small molecule compounds are emerging as an attractive alternative that can potentially overcome the drawbacks of mAb-based therapy. In this article, we present a novel class of small molecule compounds based on the terphenyl scaffold that bind to PD-L1. The general architecture of the presented structures is characterized by axial symmetry and consists of three elements: an m-terphenyl core, an additional aromatic ring, and a solubilizing agent. Using molecular docking, we designed a series of final compounds, which were subsequently synthesized and tested in HTRF assay and NMR binding assay to evaluate their activity. In addition, we performed an in-depth analysis of the mutual arrangement of the phenyl rings of the terphenyl core within the binding pocket of PD-L1 and found several correlations between the plane angle values and the affinity of the compounds towards the protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenProgrammed Cell Death 1 ReceptorMolecular Docking SimulationProtein BindingTerphenyl CompoundsHumansSmall Molecule LibrariesImmune Checkpoint InhibitorsMolecular StructureStructure-Activity RelationshipBinding Sites

Stichwörter der Autor:innen

C2-symmetrical ligandsPD-L1cancerimmune checkpointsmall molecule inhibitor

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorTerphenyl CompoundsCD274 protein, humanSmall Molecule LibrariesPDCD1 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Organic Chemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa St. 2, 30-387 Cracow, Poland.
  • Doctoral School of Exact and Natural Sciences, Jagiellonian University, Prof. St. Łojasiewicza St. 11, 30-348 Cracow, Poland.
  • Department of Drug Design, University of Groningen, 9713 AV Groningen, The Netherlands.
  • Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry and Czech Advanced Technology and Research Institute, Palackӯ University in Olomouc, Křížkovského 511/8, 779 00 Olomouc, Czech Republi…

ORCID-Profile: Joanna Klimek, Oskar Kruc, Beata Kamińska, Bogdan Musielak, Robin van der Straat, Alexander Dӧmling, Tad A Holak, Damian Muszak, Justyna Kalinowska-Tłuścik, Łukasz Skalniak, Ewa Surmiak

Förderung

  • National Science Center
  • Foundation for Polish Science
  • European Union in the framework of the Smart Growth Operational Program, Measure 4.2
  • Strategic Programme Excellence Initiative at Jagiellonian University
  • National Science Centre
  • Priority Research Area SciMat

Zitieren

APA

Klimek, J., Kruc, O., Ceklarz, J., Kamińska, B., Musielak, B., van der Straat, R., Dӧmling, A., Holak, T. A., Muszak, D., Kalinowska-Tłuścik, J., Skalniak, Ł., & Surmiak, E. (2024). C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction. Molecules, 29(11), 2646. https://doi.org/10.3390/molecules29112646

Vancouver

Klimek J, Kruc O, Ceklarz J, Kamińska B, Musielak B, van der Straat R, et al. C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction. Molecules. 2024;29(11):2646. doi:10.3390/molecules29112646

BibTeX
@article{Klimek2024,
  author = {Klimek, Joanna and Kruc, Oskar and Ceklarz, Joanna and Kamińska, Beata and Musielak, Bogdan and van der Straat, Robin and Dӧmling, Alexander and Holak, Tad A and Muszak, Damian and Kalinowska-Tłuścik, Justyna and Skalniak, Łukasz and Surmiak, Ewa},
  title = {C2-Symmetrical Terphenyl Derivatives as Small Molecule Inhibitors of Programmed Cell Death 1/Programmed Death Ligand 1 Protein–Protein Interaction},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {11},
  pages = {2646},
  doi = {10.3390/molecules29112646}
}
Kostenlos starten →